SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-000788
Filing Date
2020-01-30
Accepted
2020-01-30 16:27:54
Documents
18
Period of Report
2020-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2020janbiohaven8-k.htm   iXBRL 8-K 42528
2 EXHIBIT 1.1 exhibit112020janbiohav.htm EX-1.1 209278
3 EXHIBIT 5.1 exhibit512020janbiohav.htm EX-5.1 26738
9 exhibit51jan20208kimage1.jpg GRAPHIC 83636
10 exhibit51jan20208kimage2.jpg GRAPHIC 80046
  Complete submission text file 0001628280-20-000788.txt   679186

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20200128.xsd EX-101.SCH 4588
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20200128_cal.xml EX-101.CAL 624
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20200128_def.xml EX-101.DEF 1474
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20200128_lab.xml EX-101.LAB 26110
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20200128_pre.xml EX-101.PRE 13568
14 EXTRACTED XBRL INSTANCE DOCUMENT a2020janbiohaven8-k_htm.xml XML 4582
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 20561713
SIC: 2834 Pharmaceutical Preparations